Clinical Trials Logo

Clinical Trial Summary

Succinylcholine is a myorelaxant agent often used during rapid sequence induction for patients who need to undergo general anesthesia but who are at risk of pulmonary aspiration of gastric content. Whereas other myorelaxant agents are monitored with train of four stimulation to assess onset and duration, few anesthesiologists use train of four stimulation for onset of succinylcholine, as the anesthesiologists evaluate the effect with the time from injection (usually one minute) and the muscle fasciculation due to the release of acetylcholine.

The data available on onset duration of this drug are old and bases on only few studies, but the succinylcholine if sometime harmful (anaphylaxis , cardiac arrest, bronchospasm).

The investigators want to assess the onset time of succinylcholine with an objective toll , the train of four stimulation, and evaluate if the clinical judgment of the anesthesiologist is reliable to predict an adequate moment for endotracheal intubation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03415607
Study type Observational [Patient Registry]
Source University Hospital, Caen
Contact Clément Buléon, PH
Phone 33231063106
Email buleon-c@chu-caen.fr
Status Recruiting
Phase N/A
Start date November 6, 2017
Completion date April 2018